Evexomostat (SDX-7320) shows potent anti-tumor effects in pre-clinical models of prostate cancer, including castration-resistant.
New research data to be presented at AACR 2023 in Orlando, FL
...
November 5, 2025
Lifestyle Magazine
Evexomostat (SDX-7320) shows potent anti-tumor effects in pre-clinical models of prostate cancer, including castration-resistant.
New research data to be presented at AACR 2023 in Orlando, FL
...
